Compare IT & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IT | BAX |
|---|---|---|
| Founded | 1979 | 1931 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.2B |
| IPO Year | 2010 | 1994 |
| Metric | IT | BAX |
|---|---|---|
| Price | $149.43 | $17.64 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 9 |
| Target Price | ★ $189.25 | $21.00 |
| AVG Volume (30 Days) | 1.2M | ★ 6.3M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.65 | N/A |
| Revenue | $2,021,441,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $3.52 | $1.96 |
| Revenue Next Year | $5.08 | $2.22 |
| P/E Ratio | $15.59 | ★ N/A |
| Revenue Growth | ★ 13.30 | 5.72 |
| 52 Week Low | $139.18 | $15.73 |
| 52 Week High | $451.73 | $32.68 |
| Indicator | IT | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 50.24 |
| Support Level | $142.76 | $17.69 |
| Resistance Level | $162.87 | $18.97 |
| Average True Range (ATR) | 5.75 | 0.75 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 21.96 | 55.79 |
Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.